Vita Imaging, with a valuation of $39.94 million, is raising funds on StartEngine. The company is a medical device company developing cutting-edge cancer detection and diagnostic technology. Its lead product, AURA™, is a skin cancer detection device that has already been submitted for FDA clearance. Vita Imaging's AURA™ is an award-winning, non-invasive imaging device that can detect Melanoma & Non-Melanoma skin cancer within two seconds. Thinh Quy Tran, a Stanford engineering graduate with a track record of taking a start-up high tech company public on the NASDAQ, is the Chairman and CEO of Vita Imaging. The current crowdfunding campaign has a minimum target of $15,000 and a maximum target of $5,000,000. The campaign proceeds will be used for research and development, marketing,company employment and working capital.